Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Asset Writedowns and Impairment (2016 - 2020)

Historic Asset Writedowns and Impairment for CV Sciences (CVSI) over the last 7 years, with Q1 2020 value amounting to $46000.0.

  • CV Sciences' Asset Writedowns and Impairment rose 8400.0% to $46000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $257000.0, marking a year-over-year increase of 26197.18%. This contributed to the annual value of $251000.0 for FY2023, which is 7965.96% down from last year.
  • CV Sciences' Asset Writedowns and Impairment amounted to $46000.0 in Q1 2020, which was up 8400.0% from $198000.0 recorded in Q4 2019.
  • CV Sciences' 5-year Asset Writedowns and Impairment high stood at $3.5 million for Q4 2016, and its period low was -$1000.0 during Q2 2018.
  • Over the past 5 years, CV Sciences' median Asset Writedowns and Impairment value was $31003.0 (recorded in 2016), while the average stood at $334486.1.
  • Per our database at Business Quant, CV Sciences' Asset Writedowns and Impairment crashed by 10024.97% in 2018 and then surged by 980000.0% in 2019.
  • Quarter analysis of 5 years shows CV Sciences' Asset Writedowns and Impairment stood at $3.5 million in 2016, then crashed by 97.64% to $82565.0 in 2017, then tumbled by 97.58% to $2000.0 in 2018, then surged by 9800.0% to $198000.0 in 2019, then plummeted by 76.77% to $46000.0 in 2020.
  • Its Asset Writedowns and Impairment stands at $46000.0 for Q1 2020, versus $198000.0 for Q4 2019 and $6000.0 for Q3 2019.